About the 9th Annual ELSCEO Forum & ExhibitionThe 9th Annual ELSCEO Forum & Exhibition, is being held on 15th-16th March 2016 at the Hilton Zurich Airport Hotel, Switzerland. This event will be highly transactional, bringing together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders. We expect around 350 delegates and 80 presenting companies. Event's networking will be powered by online One-2-One meeting system and dedicated meeting facilities to make the event more transactional and productive.
Plenary Discussion Sessions include:
Confirmed Speakers & Chairs include:
Presenting Opportunities:
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering. The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners. To view confirmed presenting companies for 2016 forum click HERE
Exhibitors in 2016 include:
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events. To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia. |
Silver Sponsors:
Supported by:
Pharma Licensing Groups Attending in 2016 Include:
Financial
Advisory/Investors Confirmed for 2016: AAIPharma Services Corp. | Cambridge Major Laboratories, Inc.
Affas Besse Advisors Ltd. Austin Life Science Partners AG BioLife Solutions, Inc BioStart Consulting GmbH Bird & Bird LLP Bootstrap Europe Breslin AG Capricorn One Colpman Consulting Ltd. Corinthian Financial Management Ltd. Ernst & Young AG FreeMind Group goetzpartners holding Grabulovski Consulting Services Health Advances GmbH High Beacon Ltd. inVentiv Health, Inc. Inventiva Pharma IPSA LifeCare Partners MC Services AG Mediatum Schweiz GmbH RSA AG The Trout Group XOventure GmbH AGLAIA BioMedical Ventures B.V. ALSTIN Amorchem Aravis SA Arcus Ventures Aurum Holdings MKI Ltd. Bay City Capital LLC BB Biotech Ventures Beechwood Ventures Bellevue Asset Management AG Belmont Capital Belsize Asset Management BioBac BioValley Business Angels Club BioMedPartners AG Boehringer Ingelheim GmbH Venture Fund Brean Capital, LLC Brock Capital Group LLC ChinaBio Capital Cukierman & Co. Life Sciences Deca Ventures Eckert Life Science Accelerator GmbH (ELSA) Edison Edmond de Rothschild Investment Partners EMD Serono Enso Ventures Forbion Capital Partners Fountain Healthcare Partners Fraser Finance Fukoku Life International (UK) Ltd. fundamenta CAPITAL AG Gilde Healthcare GIMV Global Life Science Ventures HBM Partners AG HCB Healthcubator GmbH HealthCare Royalty Partners Helvea Baader Bank High-Tech Gruenderfonds Management GmbH IBM Imperial Innovations Industrifonden INKEF Capital BV InSymbiosis Capital Inveready Kreos Capital MainFirst Medicxi Ventures MedVenture Partners GmbH Merchant Liquidity Fund, LP MPM Capital MS Ventures Nasdaq Neomed Nextech Invest Ltd. Omega Funds Oppenheimer & Co., Inc. Peppermint Venture Partners GmbH PharmaVentures Ltd. Pitango Venture Capital PM Equity Partner RBV Capital Redalpine Venture Partners RMI Partners Rockport Venture Partners Rodman & Renshaw, LLC Rosetta Capital Ltd Royal Bank of Canada S.R.One, Limited Seroba Life Sciences Seventure Partners Sirius Healthcare Partners SIX Swiss Exchange Skolkovo Foundation SMR Consulting GmbH SNS Securities Sofinnova Partners Stanphyl Capital Sunstone Capital A/S Sunstone Life Science Ventures SV Life Sciences The Fulford Group Thuja Capital B.V. Torreya Partners (Europe), LLP TVM Capital China Limited TVM Life Science Management Inc. Ventac Partners VI Partners AG Visium Asset Management Vogel BioC Wellcome Trust Wellington Partners Wingspan Ventures Yorkville Advisors, LLC Ysios Capital Partners Zukunftsfonds Heilbronn GmbH & Co KG |
Sachs Associates (Switzerland) GmbH
|
Sachs Associates Ltd.
|
T: +44 203 463 4890
E: SachsTeam@SachsForum.com
© COPYRIGHT 2017. ALL RIGHTS RESERVED.
